Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|December 21, 2016
Activities of Omadacycline and Comparator Agents against Staphylococcus aureus Isolates from a Surveillance Program Conducted in North America and EuropeMichael A Pfaller, Paul R Rhomberg, Michael D Huband, et al.
Antimicrobial Agents and Chemotherapy|February 23, 2017
Surveillance of Omadacycline Activity against Clinical Isolates from a Global Collection (North America, Europe, Latin America, Asia-Western Pacific), 2010-2011Michael A Pfaller, Michael D Huband, Paul R Rhomberg, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2016
In Vitro Activity of Delafloxacin Tested against Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalisRobert K Flamm, Paul R Rhomberg, Michael D Huband, et al.
Antimicrobial Agents and Chemotherapy|April 1, 2015
In vitro antibacterial activity of AZD0914 against human Mycoplasmas and UreaplasmasKen B Waites, Donna M Crabb, Lynn B Duffy, et al.
Future Microbiology|May 20, 2022
Plain language summary: Does a person's age affect how common fungal infections are and how well drugs can kill the infections?Michael A Pfaller, Cecilia G Carvalhaes, Sean DeVries, et al.
Diagnostic Microbiology and Infectious Disease|January 20, 2022
Elderly versus nonelderly patients with invasive fungal infections: species distribution and antifungal resistance, SENTRY antifungal surveillance program 2017-2019Michael A Pfaller, Cecilia G Carvalhaes, Sean DeVries, et al.
Diagnostic Microbiology and Infectious Disease|December 26, 2017
Determination of MIC and disk diffusion quality control guidelines for meropenem-vaborbactam, a novel carbapenem/boronic acid β-lactamase inhibitor combinationErik Munson, Michael D Huband, Mariana Castanheira, et al.
Journal of Clinical Microbiology|June 24, 2025
Re-evaluation of penicillin and ceftriaxone MIC results to predict susceptibility to the oral cephalosporin, cefpodoxime, in Streptococcus pneumoniae clinical isolates from the United States according to CLSI guidelines (2019-2021)Rodrigo E Mendes, Jessica V Pierce, Kelly Wright, et al.
Diagnostic Microbiology and Infectious Disease|November 19, 2016
Effect of Susceptibility Testing Conditions on the In Vitro Antibacterial Activity of ETX0914Robert A Giacobbe, Michael D Huband, Boudewijn L M deJonge, et al.
Open Forum Infectious Diseases|September 4, 2024
High Rates of Nonsusceptibility to Common Oral Antibiotics in Streptococcus pneumoniae Clinical Isolates From the United States (2019-2021)Lalitagauri M Deshpande, Michael D Huband, Sarah Charbon, et al.
Pageof 9